The HJCC platform can generate a greater quantity and diversity of antigen-specific antibodies ..
Release time:2025-12-16
Launched its next-generation genetically modified mouse platform AlivaMab Mouse NGX for the discovery of human antibody drugs
Related news
-
HJCC has released its next-generation genetically modified mouse platform, AlivaMab Mouse NGX, for the discovery of human antibody drugs2025.12.16Learn More
-
HJCC has released its next-generation genetically modified mouse platform, AlivaMab Mouse NGX, for the discovery of human antibody drugs2025.12.16
Learn More